Response, Resistance and Metastasis of Locally Advanced Breast Cancer (LABC, Stage 2B-3C) in a Multiethnic Cohort: A Phase II International Multicentric Study of Concurrent Paclitaxel and Radiation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Dec 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2018.
- 10 Jun 2017 Biomarkers information updated
- 27 Oct 2015 Planned End Date changed from 1 Mar 2016 to 1 Dec 2020 as reported by ClinicalTrials.gov.